212 related articles for article (PubMed ID: 31792371)
1. PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients.
Franca R; Stocco G; Favretto D; Giurici N; Del Rizzo I; Locatelli F; Vinti L; Biondi A; Colombini A; Fagioli F; Barisone E; Pelin M; Martellossi S; Ventura A; Decorti G; Rabusin M
Pharmacogenomics J; 2020 Jun; 20(3):415-425. PubMed ID: 31792371
[TBL] [Abstract][Full Text] [Related]
2. PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity.
Stocco G; Yang W; Crews KR; Thierfelder WE; Decorti G; Londero M; Franca R; Rabusin M; Valsecchi MG; Pei D; Cheng C; Paugh SW; Ramsey LB; Diouf B; McCorkle JR; Jones TS; Pui CH; Relling MV; Evans WE
Hum Mol Genet; 2012 Nov; 21(21):4793-804. PubMed ID: 22846425
[TBL] [Abstract][Full Text] [Related]
3. PACSIN2 polymorphism is associated with thiopurine-induced hematological toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy.
Smid A; Karas-Kuzelicki N; Jazbec J; Mlinaric-Rascan I
Sci Rep; 2016 Jul; 6():30244. PubMed ID: 27452984
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
5. Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate.
Pettersson B; Almer S; Albertioni F; Söderhäll S; Peterson C
Ther Drug Monit; 2002 Jun; 24(3):351-8. PubMed ID: 12021625
[TBL] [Abstract][Full Text] [Related]
6. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
7. TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease.
Stocco G; Martelossi S; Barabino A; Fontana M; Lionetti P; Decorti G; Malusà N; Bartoli F; Fezzi M; Giraldi T; Ventura A
Dig Liver Dis; 2005 Dec; 37(12):940-5. PubMed ID: 16202677
[TBL] [Abstract][Full Text] [Related]
8. Role of TPMT and ITPA variants in mercaptopurine disposition.
Gerbek T; Ebbesen M; Nersting J; Frandsen TL; Appell ML; Schmiegelow K
Cancer Chemother Pharmacol; 2018 Mar; 81(3):579-586. PubMed ID: 29387964
[TBL] [Abstract][Full Text] [Related]
9.
Zudeh G; Franca R; Lucafò M; Bonten EJ; Bramuzzo M; Sgarra R; Lagatolla C; Franzin M; Evans WE; Decorti G; Stocco G
Life Sci Alliance; 2023 Mar; 6(3):. PubMed ID: 36596605
[TBL] [Abstract][Full Text] [Related]
10. Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.
Gearry RB; Barclay ML; Burt MJ; Collett JA; Chapman BA; Roberts RL; Kennedy MA
Aliment Pharmacol Ther; 2003 Aug; 18(4):395-400. PubMed ID: 12940924
[TBL] [Abstract][Full Text] [Related]
11. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
[TBL] [Abstract][Full Text] [Related]
12. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.
Peregud-Pogorzelski J; Tetera-Rudnicka E; Kurzawski M; Brodkiewicz A; Adrianowska N; Mlynarski W; Januszkiewicz D; Drozdzik M
Pediatr Blood Cancer; 2011 Oct; 57(4):578-82. PubMed ID: 21319286
[TBL] [Abstract][Full Text] [Related]
13. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine.
Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E
Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411
[TBL] [Abstract][Full Text] [Related]
14. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
[TBL] [Abstract][Full Text] [Related]
15. Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia.
Stocco G; Franca R; Verzegnassi F; Londero M; Rabusin M; Decorti G
Front Genet; 2012; 3():309. PubMed ID: 23335936
[TBL] [Abstract][Full Text] [Related]
16. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease.
Pashazadeh P; Marjani A; Asadi J; Khoshnia M
Endocr Metab Immune Disord Drug Targets; 2019; 19(4):541-547. PubMed ID: 30451123
[TBL] [Abstract][Full Text] [Related]
18. Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease.
Al-Judaibi B; Schwarz UI; Huda N; Dresser GK; Gregor JC; Ponich T; Chande N; Mosli M; Kim RB
J Popul Ther Clin Pharmacol; 2016; 23(1):e26-36. PubMed ID: 26950049
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
Daperno M; Sostegni R; Canaparo R; Serpe L; Lavagna A; Crocellà L; Castagno F; Vernetto A; Rigazio C; Ercole E; D'Antico S; Pera A; Zara G; Rocca R
Aliment Pharmacol Ther; 2009 Oct; 30(8):843-53. PubMed ID: 19650826
[TBL] [Abstract][Full Text] [Related]
20. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S
Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
